{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:34:49Z","timestamp":1779201289925,"version":"3.51.4"},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2018,8,1]]},"DOI":"10.1248\/bpb.b18-00028","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T18:36:12Z","timestamp":1533062172000},"page":"1211-1218","source":"Crossref","is-referenced-by-count":57,"title":["Dysregulation of BSEP and MRP2 May Play an Important Role in Isoniazid-Induced Liver Injury <i>via<\/i> the SIRT1\/FXR Pathway in Rats and HepG2 Cells"],"prefix":"10.1248","volume":"41","author":[{"given":"Xiaoyu","family":"Qu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sixi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghui","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The First Hospital of Jilin University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Grant LM, Rockey DC. Drug-induced liver injury. Curr. Opin. Gastroenterol.<\/i>, 28<\/b>, 198\u2013202 (2012).","DOI":"10.1097\/MOG.0b013e3283528b5d"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Khoury T, Rmeileh AA, Yosha L, Benson AA, Daher S, Mizrahi M. Drug induced liver injury: Review with a focus on genetic factors, tissue diagnosis, and treatment options. J. Clin. Transl. Hepatol.<\/i>, 3<\/b>, 99\u2013108 (2015).","DOI":"10.14218\/JCTH.2015.00007"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Schuetz JD, Swaan PW, Tweedie DJ. The role of transporters in toxicity and disease. Drug Metab. Dispos.<\/i>, 42<\/b>, 541\u2013545 (2014).","DOI":"10.1124\/dmd.114.057539"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Alrefai WA, Gill RK. Bile acid transporters: Strucure, function, regulation and pathophysiological implications. Pharm. Res.<\/i>, 24<\/b>, 1803\u20131823 (2007).","DOI":"10.1007\/s11095-007-9289-1"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Cheng Y, Freeden C, Zhang Y, Abraham P, Shen H, Wescott D, Humphreys WG, Gan J, Lai Y. Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment. Biopharm. Drug Dispos.<\/i>, 37<\/b>, 276\u2013286 (2016).","DOI":"10.1002\/bdd.2011"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Hassan HM, Guo HL, Yousef BA, Luyong Z, Zhenzhou J. Hepatotoxicity mechanisms of isoniazid: A mini-review. J. Appl. Toxicol.<\/i>, 35<\/b>, 1427\u20131432 (2015).","DOI":"10.1002\/jat.3175"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Wang P, Pradhan K, Zhong XB, Ma X. Isoniazid metabolism and hepatotoxicity. Acta Pharm. Sin. B<\/i>, 6<\/b>, 384\u2013392 (2016).","DOI":"10.1016\/j.apsb.2016.07.014"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hayashi PH, Fontana RJ, Chalasani NP, Stolz AA, Talwalkar JA, Navarro VJ, Lee WM, Davern TJ, Kleiner DE, Gu J, Hoofnagle JH. Under-reporting and poor adherence to monitoring guidelines for severe cases of isoniazid hepatotoxicity. Clin. Gastroenterol. Hepatol.<\/i>, 13<\/b>, 1676\u20131682 (2015).","DOI":"10.1016\/j.cgh.2015.02.024"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Perwitasari DA, Atthobari J, Wilffert B. Pharmacogenetics of isoniazid-induced hepatotoxicity. Drug Metab. Rev.<\/i>, 47<\/b>, 222\u2013228 (2015).","DOI":"10.3109\/03602532.2014.984070"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R. Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review. J. Gastroenterol. Hepatol.<\/i>, 23<\/b>, 192\u2013202 (2008).","DOI":"10.1111\/j.1440-1746.2007.05207.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Guo YX, Xu XF, Zhang QZ, Li C, Deng Y, Jiang P, He LY, Peng WX. The inhibition of hepatic bile acids transporters Ntcp and Bsep is involved in the pathogenesis of isoniazid\/rifampicin-induced hepatotoxicity. Toxicol. Mech. Methods<\/i>, 25<\/b>, 382\u2013387 (2015).","DOI":"10.3109\/15376516.2015.1033074"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Gonz\u00e1lez R, Cruz A, Ferrin G, L\u00f3pez-Cillero P, Brice\u00f1o J, G\u00f3mez MA, Rufl\u00e1n S, Padillo J, De la Mata M, Marin JJ, Muntane J. Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids. J Hepatobillary Pancreat Sci.<\/i>, 18<\/b>, 740\u2013750 (2011).","DOI":"10.1007\/s00534-011-0396-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Dietrich CG, Martin IV, Porn AC, Voigt AC, Gartung C, Trautwein C, Geier A. Fasting induces basolateral uptake transporters of the SLC family in the liver via<\/i> HNF4alpha and PGC1alpha. Am. J. Physiol. Gastrointest. Liver Physiol.<\/i>, 293<\/b>, G585\u2013G590 (2007).","DOI":"10.1152\/ajpgi.00175.2007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Claro da Silva T, Polli JE, Swaan PW. The solute carier family 10 (SLC10): beyond bile acid transport. Mol. Aspects Med.<\/i>, 34<\/b>, 252\u2013269 (2013).","DOI":"10.1016\/j.mam.2012.07.004"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Yang J, Sun L, Wang L, Hassan HM, Wang X, Hylemon PB, Wang T, Zhou H, Zhang L, Jiang Z. Activation of Sirt1\/FXR signaling pathway attenuates triptolide-induced hepatotoxicity in rats. Front. Pharmacol.<\/i>, 8<\/b>, 260 (2017).","DOI":"10.3389\/fphar.2017.00260"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zhang G, Zhou Y, Rao Z, Qin H, Wei Y, Ren J, Zhou L, Wu X. Effect of Yin-Zhi-Huang on up-regulation of Oatp2, Ntcp, and Mrp2 proteins in estrogen-induced rat cholestasis. Pharm. Biol.<\/i>, 53<\/b>, 319\u2013325 (2015).","DOI":"10.3109\/13880209.2014.918156"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Suchy FJ, Ananthanarayanan M. Bile salt excretory pump: biology and pathobiology. J. Pediatr. Gastroenterol. Nutr.<\/i>, 43<\/b> (Suppl. 1), S10\u2013S16 (2006).","DOI":"10.1097\/01.mpg.0000226385.71859.5f"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Zhang A, Jia Y, Xu Q, Wang C, Liu Q, Meng Q, Peng J, Sun H, Sun P, Huo X, Liu K. Dioscin protects against ANIT-induced cholestasis via<\/i> regulating Oatps, Mrp2 and Bsep expression in rats. Toxicol. Appl. Pharmacol.<\/i>, 305<\/b>, 127\u2013135 (2016).","DOI":"10.1016\/j.taap.2016.06.019"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Li X, Liu R, Yu L, Yuan Z, Sun R, Yang H, Zhang L, Jiang Z. Alpha-naphthylisothiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes. Toxicology<\/i>, 370<\/b>, 106\u2013115 (2016).","DOI":"10.1016\/j.tox.2016.09.020"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Chen H, Huang X, Min J, Li W, Zhang R, Zhao W, Liu C, Yi L, Mi S, Wang N, Wang Q, Zhu C. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2. J. Ethnopharmacol.<\/i>, 179<\/b>, 197\u2013207 (2016).","DOI":"10.1016\/j.jep.2015.12.033"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Meng Q, Chen XL, Wang CY, Liu Q, Sun HJ, Sun PY, Huo XK, Liu ZH, Yao JH, Liu KX. Alisol B 23-acetate protects against ANIT-induced hepatotoxity and cholestasis, due to FXR-mediated regulation of transporters and enzymes involved in bile acid homeostasis. Toxicol. Appl. Pharmacol.<\/i>, 283<\/b>, 178\u2013186 (2015).","DOI":"10.1016\/j.taap.2015.01.020"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Mudaliar S, Henry RR, Sanyal AJ, Morrow L, Marschall HU, Kipnes M, Adorini L, Sciacca CI, Clopton P, Castelloe E, Dillon P, Pruzanski M, Shapiro D. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology<\/i>, 145<\/b>, 574\u2013582 (2013).","DOI":"10.1053\/j.gastro.2013.05.042"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Purushotham A, Xu Q, Lu J, Foley JF, Yan X, Kim DH, Kemper JK, Li X. Hepatic deletion of SIRT1 decreases hepatocyte nuclear factor 1\u03b1\/farnesoid X receptor signaling and induces formation of cholesterol gallstones in mice. Mol. Cell. Biol.<\/i>, 32<\/b>, 1226\u20131236 (2012).","DOI":"10.1128\/MCB.05988-11"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Garcia-Rodriguez JL, Barbier-Torres L, Fernandez-Alvarez S, Gutierrez-de Juan V, Monte MJ, Halilbasic E, Herranz D, Alvarez L, Aspichueta P, Marin JJ, Trauner M, Mato JM, Serrano M, Beraza N, Martinez-Chantar ML. SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling. Hepatology<\/i>, 59<\/b>, 1972\u20131983 (2014).","DOI":"10.1002\/hep.26971"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Han C, Wan H, Ma S, Liu D, He F, Wang J, Pan Z, Liu H, Li L, He H, Xu H, Wei S, Xu F. Role of mammalian sirtuin 1 (SIRT1) in lipids metabolism and cell proliferation of goose primary hepatocytes. Mol. Cell. Endocrinol.<\/i>, 382<\/b>, 282\u2013291 (2014).","DOI":"10.1016\/j.mce.2013.10.012"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kazgan N, Metukuri MR, Purushotham A, Lu J, Rao A, Lee S, Pratt-Hyatt M, Lickteig A, Csanaky IL, Zhao Y, Dawson PA, Li X. Intestine-specific deletion of Sirt1 in mice impairs DCoH2-HNF1\u03b1-FXR signaling and alters systemic bile acid homeostasis. Gastroenterology<\/i>, 146<\/b>, 1006\u20131016 (2014).","DOI":"10.1053\/j.gastro.2013.12.029"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yu L, Liu X, Yuan Z, Li X, Yang H, Yuan Z, Sun L, Zhang L, Jiang Z. SRT1720 alleviates ANIT-induced cholestasis in a mouse model. Front. Pharmacol.<\/i>, 8<\/b>, 256 (2017).","DOI":"10.3389\/fphar.2017.00256"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Wang Y, Jiang Y, Fan X, Tan H, Zeng H, Wang Y, Chen P, Huang M, Bi H. Hepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1-p53 signaling pathways. Toxicol. Lett.<\/i>, 236<\/b>, 82\u201389 (2015).","DOI":"10.1016\/j.toxlet.2015.05.001"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/8\/41_b18-00028\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T00:11:42Z","timestamp":1533341502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/41\/8\/41_b18-00028\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00028","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]}}}